Respiratory Medicine
Volume 103, Issue 8 , Pages 1114-1121 , August 2009

Indicators for steroid response in biopsy proven acute graft rejection after lung transplantation

  • T. Fuehner

      Affiliations

    • Department of Respiratory Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49 5115328505.
    • ,
  • A. Simon

      Affiliations

    • Department of Cardiothoracic, Transplantation and Vascular Surgery, Hannover Medical School, Germany
    • ,
  • M. Dierich

      Affiliations

    • Department of Respiratory Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany
    • ,
  • C. DeWall

      Affiliations

    • Department of Respiratory Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany
    • ,
  • F. Laenger

      Affiliations

    • Institute of Pathology, Hannover Medical School, Germany
    • ,
  • M.W. Pletz

      Affiliations

    • Department of Respiratory Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany
    • ,
  • T. Welte

      Affiliations

    • Department of Respiratory Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany
    • ,
  • J. Gottlieb

      Affiliations

    • Department of Respiratory Medicine, Hannover Medical School, Carl-Neuberg-Str. 1, 30625 Hannover, Germany

Received 23 January 2009 ,Accepted 6 March 2009.

References 

  1. Lynch JP, Saggar R, Weigt SS, Ross DJ, Belperio JA. Overview of lung transplantation and criteria for selection of candidates. Semin Respir Crit Care Med. 2006 Oct;27(5):441–469
  2. Boehler A, Estenne M. Post-transplant bronchiolitis obliterans. Eur Respir J. 2003;22:1007–1018
  3. Kroshus TJ, Kshettry VR, Savik K, John R, Hertz MI, Bolman RM. Risk factors for the development of bronchiolitis obliterans syndrome after lung transplantation. J Thorac Cardiovasc Surg. 1997;114:195–202
  4. Heng D, Sharples LD, McNeil K, Stewart S, Wreghitt T, Wallwork J. Bronchiolitis obliterans syndrome: incidence, natural history, prognosis, and risk factors. J Heart Lung Transplant. 1998;17:1255–1263
  5. Sharples LD, McNeil K, Stewart S, Wallwork J. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant. 2002;21:271–281
  6. Stewart S, Fishbein MC, Snell GI, Berry GJ, Boehler A, Burke MM, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant. 2007 Dec;26(12):1229–1242
  7. Snell GI, Boehler A, Glanville AR, McNeil K, Scott JP, Studer SM, et al. Eleven years on: a clinical update of key areas of the 1996 lung allograft rejection working formulation. J Heart Lung Transplant. 2007 May;26(5):423–430
  8. Billingham M, Kobashigawa JA. The revised ISHLT heart biopsy grading scale. J Heart Lung Transplant. 2005 Nov;24(11):1709
  9. Bando K, Paradis IL, Similo S, Konishi H, Komatsu K, Zullo TG, et al. Obliterative bronchiolitis after lung and heart–lung transplantation. An analysis of risk factors and management. J Thorac Cardiovasc Surg. 1995;110:4–13
  10. Girgis RE, Tu I, Berry GJ, Reichenspurner H, Valentine VG, Conte JV, et al. Risk factors for the development of obliterative bronchiolitis after lung transplantation. J Heart Lung Transplant. 1996;15:1200–1208
  11. Husain AN, Siddiqui MT, Holmes EW, Chandrasekhar AJ, McCabe M, Radvany R, et al. Analysis of risk factors for the development of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med. 1999;159:829–833
  12. Hachem RR, Khalifah AP, Chakinala MM, Yusen RD, Aloush AA, Mohanakumar T, et al. The significance of a single episode of minimal acute rejection after lung transplantation. Transplantation. 2005;80:1406–1413
  13. Khalifah AP, Hachem RR, Chakinala MM, Yusen RD, Aloush A, Patterson GA, et al. Minimal acute rejection after lung transplantation: a risk for bronchiolitis obliterans syndrome. Am J Transplant. 2005;5:2022–2030
  14. Higenbottam T, Stewart S, Penketh A, Wallwork J. Transbronchial lung biopsy for diagnosis of rejection in heart–lung transplant patients. Transplantation. 1988;46:532–539
  15. Otulana BA, Higenbottam T, Ferrari L, Scott J, Igboaka G, Wallwork J. The use of home spirometry in detecting acute lung rejection and infection following heart–lung transplantation. Chest. 1990;97:353–357
  16. Van Muylem A, Melot C, Antoine M, Knoop C, Estenne M. Role of pulmonary function in the detection of allograft dysfunction after heart–lung transplantation. Thorax. 1997;52:643–647
  17. Becker FS, Martinez FJ, Brunsting LA, Deeb GM, Flint A, Lynch JP. Limitations of spirometry in detecting rejection after single-lung transplantation. Am J Respir Crit Care Med. 1994;150:159–166
  18. Bjortuft O, Geiran OR, Fjeld J, Skovlund E, Johansen B, Boe J. Single lung transplantation for chronic obstructive pulmonary disease: pulmonary function and impact of bronchiolitis obliterans syndrome. Respir Med. 1996;90:553–559
  19. Finkelstein SM, Snyder M, Edin-Stibbe C, Chlan L, Prasad B, Dutta P, et al. Monitoring progress after lung transplantation from home–patient adherence. J Med Eng Technol. 1996;20:203–210
  20. Finkelstein SM, Snyder M, Stibbe CE, Lindgren B, Sabati N, Killoren T, et al. Staging of bronchiolitis obliterans syndrome using home spirometry. Chest. 1999;116:120–126
  21. Lindgren BR, Finkelstein SM, Prasad B, Dutta P, Killoren T, Scherber J, et al. Determination of reliability and validity in home monitoring data of pulmonary function tests following lung transplantation. Res Nurs Health. 1997;20:539–550
  22. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies, Gac Sanit. 2008;22(2):144–150
  23. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group; National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008 Jun 15;46(12):1813–1821
  24. Ljungman P, Griffiths P, Paya C. Definitions of cytomegalovirus infection and disease in transplant recipients. Clin Infect Dis. 2002 Apr 15;34(8):1094–1097
  25. Brusasco V, Crapo R, Viegi G American Thoracic Society European Respiratory Society. Coming together: the ATS/ERS consensus on clinical pulmonary function testing. Eur Respir J. 2005 Jul;26(1):1–2
  26. Berry GJ, Brunt EM, Chamberlain D, Hruban RH, Sibley RK, Stewart S, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: Lung Rejection Study Group. The International Society for Heart Transplantation. J Heart Transplant. 1990 Nov–Dec;9(6):593–601
  27. De Geest S, Dobbels F, Fluri C, Paris W, Troosters T. Adherence to the therapeutic regimen in heart, lung, and heart–lung transplant recipients. J Cardiovasc Nurs. 2005 Sep–Oct;20(5 Suppl.):S88–S98
  28. Mogayzel PJ, Yang SC, Wise BV, Colombani PM. Eosinophilic infiltrates in a pulmonary allograft: a case and review of the literature. J Heart Lung Transplant. 2001 Jun;20(6):692–695
  29. Stephenson A, Flint J, English J, Vedal S, Fradet G, Chittock D, et al. Interpretation of transbronchial lung biopsies from lung transplant recipients: inter- and intraobserver agreement. Can Respir J. 2005 Mar;12(2):75–77
  30. Valentine VG, Taylor DE, Dhillon GS, Knower MT, McFadden PM, Fuchs DM, et al. Success of lung transplantation without surveillance bronchoscopy. J Heart Lung Transplant. 2002 Mar;21(3):319–326
  31. Glanville AR. The role of bronchoscopic surveillance monitoring in the care of lung transplant recipients. Semin Respir Crit Care Med. 2006 Oct;27(5):480–491
  32. Trulock EP, Ettinger NA, Brunt EM, Pasque MK, Kaiser LR, Cooper JD. The role of transbronchial lung biopsy in the treatment of lung transplant recipients. An analysis of 200 consecutive procedures. Chest. 1992 Oct;102(4):1049–1054
  33. Sibley RK, Berry GJ, Tazelaar HD, Kraemer MR, Theodore J, Marshall SE, et al. The role of transbronchial biopsies in the management of lung transplant recipients. J Heart Lung Transplant. 1993 Mar-Apr;12(2):308–324
  34. Martinu T, Howell DN, Davis RD, Steele MP, Palmer SM. Pathologic correlates of bronchiolitis obliterans syndrome in pulmonary retransplant recipients. Chest. 2006 Apr;129(4):1016–1023
  35. Kukafka DS, O'Brien GM, Furukawa S, Criner GJ. Surveillance bronchoscopy in lung transplant recipients. Chest. 1997 Feb;111(2):377–381
  36. Hopkins P, McNeil K, Kermeen F, Musk M, McQueen E, Mackay I, et al. Human metapneumovirus in lung transplant recipients and comparison to respiratory syncytial virus. Am J Respir Crit Care Med. 2008 Oct 15;178(8):876–881

PII: S0954-6111(09)00085-7

doi: 10.1016/j.rmed.2009.03.013

Respiratory Medicine
Volume 103, Issue 8 , Pages 1114-1121 , August 2009

Article Tools

* Image Usage & Resolution